True Leaf’s mission is to advance health and wellness by pioneering safe, effective hemp and cannabis treatments that improve the quality of life for people and pets.
Invest in True Leaf Medicine
$250.00 Investment Minimum
True Leaf Medicine International Ltd.
Invest with a Purpose
True Leaf Medicine
True Leaf Pet is the first to successfully leverage the beneficial properties of hemp and other scientifically proven ingredients to create functional pet products that improve quality of life.
True Leaf Medicine is in the final stages of becoming a licensed producer of medicinal cannabis under the Canadian government’s Access to Cannabis for Medicinal Purposes Regulations (ACMPR).
True Leaf Pet
The American Pet Products Association reports that the amount of global spending on pets grew from $55.72B in 2013 to in $66.75B in 2016.
Pet Spending Growth
Become an Early Investor
SEC Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that True Leaf Medicine Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.
No money or consideration is being solicited by the information on this website or any other communication and, if sent, money will not be accepted and will be promptly returned. No offer by a potential investor to buy our securities can be accepted and, if made, any such offer can be withdrawn before qualification of this offering by the SEC. A potential investor’s indication of interest does not create a commitment to purchase the securities we are offering. Any such indication of interest may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance is given and all other requirements to accept an investment from a potential investor are met after the offering qualification date.
This Presentation (the “Presentation”) has been prepared solely for informational purposes by True Leaf
Medicine International Ltd. (“True Leaf”) and is being furnished through Boustead Securities, LLC
(“Boustead Securities”) solely for use by prospective investors and other third parties in connection with
their consideration of an investment in True Leaf. This presentation is not, and should not be assumed
to be, complete. This presentation has been prepared to assist interested parties in making their own
evaluation of True Leaf and does not purport to contain all of the information that may be relevant. In
all cases, interested parties should conduct their own investigation and analysis of True Leaf and the
data set forth in this presentation and other information provided by or on behalf of True Leaf. Any
views and opinions expressed in this presentation are those of True Leaf and do not necessarily
represent facts. In addition, certain of the information contained herein may be derived from
information provided by industry sources. True Leaf believes that such information is accurate and that
the sources from which it has been obtained are reliable. True Leaf cannot guarantee the accuracy of
such information, however, and has not independently verified such information. The information
presented herein remains subject to change. Statements in this presentation are made as of the date of
this presentation unless stated otherwise.
This presentation also contains statements that, to the extent they are not recitations of historical fact,
constitute “forward-looking statements.” Forward-looking statements are typically identified by the use
of terms such as “may,” “should,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”
“believe,” “continue,” “predict,” “potential” or the negative of such terms and other comparable
terminology. The forward-looking statements included herein are based upon True Leaf’s current
expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties.
Assumptions relating to the foregoing involve judgments with respect to, among other things, future
economic, competitive and market conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond True Leaf’ control. Although True Leaf
believes that the expectations reflected in such forward-looking statements are based on reasonable
assumptions, True Leaf’ actual results and performance and the value of its securities could differ
materially from those set forth in the forward-looking statements due to the impact of many factors
including, but not limited to, risks and uncertainties detailed in the “Risk Factors” in the Risk Factors
section of True Leaf’ Offering Circular on Form 1-A, filed with the U.S. Securities and Exchange
Commission and other discussions of risk factors contained in True Leaf’s periodic filings or supplements
to the offering circular. True Leaf Offering Circular on Form 1-A can be found at
https://www.trueleaf.com/pages/investor. True Leaf claims the safe harbor protection for forward
looking statements contained in the Private Securities Litigation Reform Act of 1995. True Leaf
undertakes no obligation to update or revise any such information for any reason after the date of this
presentation, unless required by law.
Investment in True Leaf’s securities involves significant risks. You should purchase these securities only if
you can afford a complete loss of your investment.
When you partner with True Leaf, you become part of the family. In addition to receiving shares, you will also receive some perks for supporting the company’s growth.
Your benefits could include: